Black Friday Sale - Ends Soon!
-35% Off Everything
Regeneron Pharmaceuticals, Inc. (REGN)
Last Price$750.2(0.6%)
Market Cap$130.3B
REGN overview
Crunching data... Almost there!
1W 1.7%
1M (19.1%)
6M (22.4%)
YTD (17.1%)
1Y (7.2%)
3Y 14.6%
5Y 103.3%
10Y 83.6%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
REGN key stats
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!
REGN Intrinsic value
REGN Intrinsic value overview
REGN Historical intrinsic value
REGN Financials
REGN Income statement
Crunching data... Almost there!
REGN Balance sheet
Crunching data... Almost there!
REGN Cash flow statement
Crunching data... Almost there!
REGN Financial ratios
REGN Growth
Crunching data... Almost there!
REGN Returns on capital
Crunching data... Almost there!
Compare with peers: operational metrics
Growth & profitability
Solvency & returns
Crunching data... Almost there!
Wall Street estimates
Price target
Crunching data... Almost there!
Crunching data... Almost there!
EPS Surprises
Crunching data... Almost there!
Looking for the most undervalued companies?
Here's our top picks.
Crunching data... Almost there!
Discover more REGN fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
What is the Intrinsic Value of Regeneron Pharmaceuticals, Inc. (REGN) stock?
As of today, intrinsic value of Regeneron Pharmaceuticals, Inc. is $863.7.
Is Regeneron Pharmaceuticals, Inc. (REGN) stock undervalued or overvalued?
As of today, Regeneron Pharmaceuticals, Inc. is undervalued by 15.1%, compared to the current market share price of $750.2.
What is Regeneron Pharmaceuticals, Inc. (REGN) stock rating?
As of today, Regeneron Pharmaceuticals, Inc. has a stock rating of 6 (out of 10), which is considered Good.
is Regeneron Pharmaceuticals, Inc. (REGN) a good stock to buy?
As of today, Regeneron Pharmaceuticals, Inc. has a Good stock rating, which is 15.1% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.